Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 112, Issue 6, Pages 1027-1036
Publisher
Springer Nature
Online
2015-03-06
DOI
10.1038/bjc.2015.72
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influence of Interferon-Alpha Combined with Chemo (Radio) Therapy on Immunological Parameters in Pancreatic Adenocarcinoma
- (2014) Svetlana Karakhanova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
- (2013) M Stotz et al. BRITISH JOURNAL OF CANCER
- Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
- (2013) Alexandr V. Bazhin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy
- (2013) Isabela Pedroza-Pacheco et al. Cellular & Molecular Immunology
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer
- (2013) Alexandr V Bazhin et al. OncoImmunology
- Open-Label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients With Resected Pancreatic Adenocarcinoma
- (2012) Jan Schmidt et al. JOURNAL OF CLINICAL ONCOLOGY
- A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma
- (2011) Stephen L. Chan et al. CANCER
- Near Eradication of Clinically Relevant Concentrations of Human Tumor Cells by Interferon-Activated Monocytes In Vitro
- (2011) Samuel Baron et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activated Monocytes Prime Naïve T Cells Against Autologous Cancer: Vigorous Cancer Destruction In Vitro and In Vivo
- (2011) B. Laumbacher et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE)
- (2010) E. LEVY et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunology of Gynecologic Neoplasms: Analysis of the Prognostic Significance of the Immune Status
- (2009) F. Bellati et al. CURRENT CANCER DRUG TARGETS
- Predictors of response to interferon therapy
- (2009) Helen Gogas et al. CURRENT OPINION IN ONCOLOGY
- The Use of Genomics in Clinical Trial Design
- (2008) R. Simon CLINICAL CANCER RESEARCH
- Antigen presentation by monocytes and monocyte-derived cells
- (2007) Gwendalyn J Randolph et al. CURRENT OPINION IN IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started